Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,559 | -1,035 | -1,405 | -1,286 | -1,055 |
| Depreciation Amortization | 279 | 172 | 81 | 222 | 174 |
| Accounts receivable | -15 | -15 | -9 | -7 | -1 |
| Accounts payable and accrued liabilities | -30 | -9 | 7 | 61 | 80 |
| Other Working Capital | 23 | -86 | -94 | 393 | 438 |
| Other Operating Activity | 359 | 280 | 1,015 | 193 | 118 |
| Operating Cash Flow | $-944 | $-693 | $-405 | $-424 | $-246 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26 | -26 | -26 | N/A | N/A |
| Other Investing Activity | -25 | -25 | 0 | 41 | 33 |
| Investing Cash Flow | $-51 | $-51 | $-26 | $41 | $33 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,276 | 1,100 | 575 | 759 | 563 |
| Debt Repayment | -427 | -313 | -167 | -553 | -421 |
| Other Financing Activity | 113 | 0 | 0 | 212 | 70 |
| Financing Cash Flow | $962 | $787 | $409 | $419 | $213 |
| Beginning Cash Position | 36 | 36 | 36 | N/A | N/A |
| End Cash Position | 4 | 79 | 14 | 36 | N/A |
| Net Cash Flow | $-33 | $43 | $-23 | $36 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -944 | -693 | -405 | -424 | -246 |
| Capital Expenditure | -26 | -26 | -26 | N/A | N/A |
| Free Cash Flow | -970 | -720 | -431 | -424 | -246 |